-OZONENEWS-

Independent · Verified · In-Depth

Eledon Pharmaceuticals

1 article tagged with “Eledon Pharmaceuticals”. Verified news, source-cited reporting, and in-depth coverage from OzoneNews.

1 article

ONN
Biotech & Health

Eledon Pharmaceuticals Overview: Clinical-Stage Biotech Focused on CD40L Pathway Therapies

Eledon Pharmaceuticals (Nasdaq: ELDN) develops tegoprubart, an IgG1 anti-CD40L antibody designed to prevent organ transplant rejection with its mission of One Transplant for Life.

OzoneNews Editorial Team · Mar 5, 2026